Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells

This publication has 13 references indexed in Scilit:

• Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER update
  Medical and Pediatric Oncology, 2002
• Childhood cancer treatment causes complications later in life
  The Lancet Oncology, 2002
• Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines
  Oncogene, 2002
• Focus on central nervous system neoplasia
  Cancer Cell, 2002
• The Daily Oral Administration of High Doses of trans-Resveratrol to Rats for 28 Days Is Not Harmful
  Journal of Nutrition, 2002
• Unusual Delayed Complication of Central Venous Access
  Journal of Pediatric Hematology/Oncology, 2001
• Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells
  Cell Death & Differentiation, 2000
• Medulloblastoma: Clinical and biologic aspects
  Neuro-Oncology, 1999
• Chemopreventive Agent Resveratrol, a Natural Product Derived From Grapes, Triggers CD95 Signaling-Dependent Apoptosis in Human Tumor Cells
  Blood, 1998
• IL-6 Stimulates Growth and Inhibits Constitutive, Protein Synthesis-Independent Apoptosis of Murine B-Cell Hybridoma 7TD1
  Cellular Immunology, 1994